Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""Demarzo MG"" wg kryterium: Autor


Wyświetlanie 1-11 z 11
Tytuł:
Reduction of Fecal Calprotectin Levels Induced by a Short Course of Escherichia Coli Nissle is Associated with a Lower Likelihood of Disease Flares in Patients with Ulcerative Colitis in Clinical Remission.
Autorzy:
Bodini G; Gastroenterology Unit, Department of Internal Medicine, IRCCS Ospedale Policlinico San Martino, Genoa, Italy. .
Ghezzi A; Gastroenterology Unit, Department of Internal Medicine, IRCCS Ospedale Policlinico San Martino, Genoa, Italy. .
Pasta A; Gastroenterology Unit, Department of Internal Medicine, IRCCS Ospedale Policlinico San Martino, Genoa, Italy. .
Marabotto E; Gastroenterology Unit, Department of Internal Medicine, IRCCS Ospedale Policlinico San Martino, Genoa, Italy. .
Calabrese F; Gastroenterology Unit, Department of Internal Medicine, IRCCS Ospedale Policlinico San Martino, Genoa, Italy. .
Facchini C; Gastroenterology Unit, Department of Internal Medicine, IRCCS Ospedale Policlinico San Martino, Genoa, Italy. .
Demarzo MG; Gastroenterology Unit, Department of Internal Medicine, IRCCS Ospedale Policlinico San Martino, Genoa, Italy. mgiulia.demarzo@gmail.com.
Giannini EG; Gastroenterology Unit, Department of Internal Medicine, IRCCS Ospedale Policlinico San Martino, Genoa, Italy. .
Pokaż więcej
Źródło:
Journal of gastrointestinal and liver diseases : JGLD [J Gastrointestin Liver Dis] 2023 Dec 22; Vol. 32 (4), pp. 438-443. Date of Electronic Publication: 2023 Dec 22.
Typ publikacji:
Journal Article
MeSH Terms:
Colitis, Ulcerative*/therapy
Colitis, Ulcerative*/drug therapy
Crohn Disease*/diagnosis
Crohn Disease*/therapy
Inflammatory Bowel Diseases*
Humans ; Leukocyte L1 Antigen Complex ; Symptom Flare Up ; Biomarkers ; Inflammation ; Feces ; Remission Induction ; Escherichia coli
Czasopismo naukowe
Tytuł:
Low Adherence is Associated with Chronic Active Disease in Ulcerative Colitis: A Retrospective Study from a Single Referral Center.
Autorzy:
Viola A; Department of Clinical and Experimental Medicine, IBD-Unit, University of Messina, Messina, Italy.
Demarzo MG; Department of Clinical and Experimental Medicine, IBD-Unit, University of Messina, Messina, Italy.; Department of Internal Medicine, Ospedale Policlinico San Martino-IRCCS per l'Oncologia, Gastroenterology Unit, University of Genoa, Genoa, Italy.
Abbruzzese A; Department of Clinical and Experimental Medicine, IBD-Unit, University of Messina, Messina, Italy.; Department of Health Promotion, Mother & Child Care, Internal Medicine & Medical Specialties, PROMISE, Gastroenterology & Hepatology Unit, University of Palermo, Palermo, Italy.
Muscianisi M; Department of Clinical and Experimental Medicine, IBD-Unit, University of Messina, Messina, Italy.
Chiappetta MF; Department of Clinical and Experimental Medicine, IBD-Unit, University of Messina, Messina, Italy.; Department of Health Promotion, Mother & Child Care, Internal Medicine & Medical Specialties, PROMISE, Gastroenterology & Hepatology Unit, University of Palermo, Palermo, Italy.
Costantino G; Department of Clinical and Experimental Medicine, IBD-Unit, University of Messina, Messina, Italy.
Ksissa O; Department of Clinical and Experimental Medicine, IBD-Unit, University of Messina, Messina, Italy.; Department of Health Promotion, Mother & Child Care, Internal Medicine & Medical Specialties, PROMISE, Gastroenterology & Hepatology Unit, University of Palermo, Palermo, Italy.
Alibrandi A; Department of Economics; Unit of Statistical and Mathematical Sciences, University of Messina, Messina, Italy.
Fries W; Department of Clinical and Experimental Medicine, IBD-Unit, University of Messina, Messina, Italy.
Pokaż więcej
Źródło:
Patient preference and adherence [Patient Prefer Adherence] 2023 Mar 23; Vol. 17, pp. 807-816. Date of Electronic Publication: 2023 Mar 23 (Print Publication: 2023).
Typ publikacji:
Journal Article
Czasopismo naukowe
Tytuł:
Letter: the clinical course of Crohn's disease-the Sicilian experience.
Autorzy:
Demarzo MG; Gastroenterology Unit, Department of Internal Medicine, University of Genoa, IRCCS Ospedale Policlinico San Martino, Genoa, Italy.; Inflammatory bowel disease Unit, A.O.U. Policlinico 'G. Martino', Messina, Italy.
Viola A; Inflammatory bowel disease Unit, A.O.U. Policlinico 'G. Martino', Messina, Italy.
Picci A; Gastroenterology Unit, Department of Internal Medicine, University of Genoa, IRCCS Ospedale Policlinico San Martino, Genoa, Italy.
Fries W; Inflammatory bowel disease Unit, A.O.U. Policlinico 'G. Martino', Messina, Italy.
Pokaż więcej
Źródło:
Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2022 May; Vol. 55 (9), pp. 1237-1238.
Typ publikacji:
Letter; Comment
MeSH Terms:
Crohn Disease*/diagnosis
Humans
Opinia redakcyjna
Tytuł:
Elevated Adherence to Vaccination Against SARS-CoV-2 Among Patients with Inflammatory Bowel Disease.
Autorzy:
Giannini EG; Gastroenterology Unit, Department of Internal Medicine, University of Genoa, IRCCS Ospedale Policlinico San Martino, Genoa,Italy.
Demarzo MG; Gastroenterology Unit, Department of Internal Medicine, University of Genoa, IRCCS Ospedale Policlinico San Martino, Genoa,Italy.
Bodini G; Gastroenterology Unit, Department of Internal Medicine, University of Genoa, IRCCS Ospedale Policlinico San Martino, Genoa,Italy.
Pokaż więcej
Źródło:
Journal of Crohn's & colitis [J Crohns Colitis] 2021 Dec 18; Vol. 15 (12), pp. 2142-2143.
Typ publikacji:
Journal Article
MeSH Terms:
COVID-19 Vaccines*
Patient Compliance*
COVID-19/*prevention & control
Inflammatory Bowel Diseases/*psychology
Humans
Czasopismo naukowe
Tytuł:
Letter: predictive factors for treatment discontinuation in IBD-anti-TNF trough levels and anti-drug antibodies.
Autorzy:
Demarzo MG; Gastroenterology Unit, Department of Internal Medicine, University of Genoa, IRCCS Ospedale Policlinico San Martino, Genoa, Italy.
Bodini G; Gastroenterology Unit, Department of Internal Medicine, University of Genoa, IRCCS Ospedale Policlinico San Martino, Genoa, Italy.
Giuliana E; Gastroenterology Unit, Department of Internal Medicine, University of Genoa, IRCCS Ospedale Policlinico San Martino, Genoa, Italy.
Zentilin P; Gastroenterology Unit, Department of Internal Medicine, University of Genoa, IRCCS Ospedale Policlinico San Martino, Genoa, Italy.
Giannini EG; Gastroenterology Unit, Department of Internal Medicine, University of Genoa, IRCCS Ospedale Policlinico San Martino, Genoa, Italy.
Pokaż więcej
Źródło:
Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2021 Aug; Vol. 54 (4), pp. 536-537.
Typ publikacji:
Letter; Comment
MeSH Terms:
Inflammatory Bowel Diseases*/drug therapy
Tumor Necrosis Factor Inhibitors*
Adalimumab/therapeutic use ; Antibodies ; Humans ; Infliximab
Opinia redakcyjna
Tytuł:
Adalimumab biosimilars, ABP501 and SB5, are equally effective and safe as adalimumab originator.
Autorzy:
Cingolani L; Division of Gastroenterology, Department of Surgery, Oncology and Gastroenterology (DiSCOG), University of Padua, Via Giustiniani 2, 35121, Padua, Italy.
Barberio B; Division of Gastroenterology, Department of Surgery, Oncology and Gastroenterology (DiSCOG), University of Padua, Via Giustiniani 2, 35121, Padua, Italy.
Zingone F; Division of Gastroenterology, Department of Surgery, Oncology and Gastroenterology (DiSCOG), University of Padua, Via Giustiniani 2, 35121, Padua, Italy. .
Ferronato A; Endoscopy Unit, Alto Vicentino Hospital, AULSS7, Pedemontana, Italy.
Bertani L; Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, Pisa, Italy.
Costa F; Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, Pisa, Italy.
Bodini G; Gastroenterology Unit, Department of Internal Medicine, IRCCS Ospedale Policlinico San Martino, University of Genoa, Genoa, Italy.
Demarzo MG; Gastroenterology Unit, Department of Internal Medicine, IRCCS Ospedale Policlinico San Martino, University of Genoa, Genoa, Italy.
Melatti P; Division of Gastroenterology, Department of Surgery, Oncology and Gastroenterology (DiSCOG), University of Padua, Via Giustiniani 2, 35121, Padua, Italy.
Gubbiotti A; Division of Gastroenterology, Department of Surgery, Oncology and Gastroenterology (DiSCOG), University of Padua, Via Giustiniani 2, 35121, Padua, Italy.
Massimi D; Division of Gastroenterology, Department of Surgery, Oncology and Gastroenterology (DiSCOG), University of Padua, Via Giustiniani 2, 35121, Padua, Italy.
Casadei C; Division of Gastroenterology, Department of Surgery, Oncology and Gastroenterology (DiSCOG), University of Padua, Via Giustiniani 2, 35121, Padua, Italy.
D'Incà R; Division of Gastroenterology, Department of Surgery, Oncology and Gastroenterology (DiSCOG), University of Padua, Via Giustiniani 2, 35121, Padua, Italy.
Savarino EV; Division of Gastroenterology, Department of Surgery, Oncology and Gastroenterology (DiSCOG), University of Padua, Via Giustiniani 2, 35121, Padua, Italy.
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2021 May 14; Vol. 11 (1), pp. 10368. Date of Electronic Publication: 2021 May 14.
Typ publikacji:
Controlled Clinical Trial; Journal Article; Multicenter Study
MeSH Terms:
Drug Substitution*
Adalimumab/*administration & dosage
Biosimilar Pharmaceuticals/*administration & dosage
Inflammatory Bowel Diseases/*drug therapy
Adalimumab/adverse effects ; Adult ; Biomarkers/analysis ; Biosimilar Pharmaceuticals/adverse effects ; C-Reactive Protein/analysis ; Feces/chemistry ; Female ; Humans ; Inflammatory Bowel Diseases/blood ; Inflammatory Bowel Diseases/diagnosis ; Leukocyte L1 Antigen Complex/analysis ; Male ; Middle Aged ; Prospective Studies ; Treatment Outcome
Czasopismo naukowe
Tytuł:
Letter: vedolizumab or a second anti-TNF-no difference in efficacy for primary biologic failures with IBD.
Autorzy:
Demarzo MG; Gastroenterology Unit, Department of Internal Medicine, University of Genoa, IRCCS Ospedale Policlinico San Martino, Genoa, Italy.
Bodini G; Gastroenterology Unit, Department of Internal Medicine, University of Genoa, IRCCS Ospedale Policlinico San Martino, Genoa, Italy.
Vanello M; Gastroenterology Unit, Department of Internal Medicine, University of Genoa, IRCCS Ospedale Policlinico San Martino, Genoa, Italy.
Martini M; Gastroenterology Unit, Department of Internal Medicine, University of Genoa, IRCCS Ospedale Policlinico San Martino, Genoa, Italy.
Giannini EG; Gastroenterology Unit, Department of Internal Medicine, University of Genoa, IRCCS Ospedale Policlinico San Martino, Genoa, Italy.
Pokaż więcej
Źródło:
Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2021 May; Vol. 53 (9), pp. 1044-1045.
Typ publikacji:
Letter; Comment
MeSH Terms:
Biological Products*/therapeutic use
Inflammatory Bowel Diseases*/drug therapy
Pharmaceutical Preparations*
Antibodies, Monoclonal, Humanized ; Humans ; Sweden ; Tumor Necrosis Factor-alpha
Opinia redakcyjna
Tytuł:
Course of oesophageal varices and performance of noninvasive predictors following Hepatitis C Virus clearance in compensated advanced chronic liver disease.
Autorzy:
Giannini EG; Gastroenterology Unit, Department of Internal Medicine, IRCCS-Ospedale Policlinico San Martino, University of Genoa, Genoa, Italy.
De Maria C; Gastroenterology Unit, Department of Internal Medicine, IRCCS-Ospedale Policlinico San Martino, University of Genoa, Genoa, Italy.
Crespi M; Gastroenterology Unit, Department of Internal Medicine, IRCCS-Ospedale Policlinico San Martino, University of Genoa, Genoa, Italy.
Demarzo MG; Gastroenterology Unit, Department of Internal Medicine, IRCCS-Ospedale Policlinico San Martino, University of Genoa, Genoa, Italy.
Fazio V; Gastroenterology Unit, Department of Internal Medicine, San Paolo Hospital, Savona, Italy.
Grasso A; Gastroenterology Unit, Department of Internal Medicine, San Paolo Hospital, Savona, Italy.
Torre F; Gastroenterology Unit, Department of Internal Medicine, IRCCS-Ospedale Policlinico San Martino, University of Genoa, Genoa, Italy.
Bodini G; Gastroenterology Unit, Department of Internal Medicine, IRCCS-Ospedale Policlinico San Martino, University of Genoa, Genoa, Italy.
Marabotto E; Gastroenterology Unit, Department of Internal Medicine, IRCCS-Ospedale Policlinico San Martino, University of Genoa, Genoa, Italy.
Furnari M; Gastroenterology Unit, Department of Internal Medicine, IRCCS-Ospedale Policlinico San Martino, University of Genoa, Genoa, Italy.
Pokaż więcej
Źródło:
European journal of clinical investigation [Eur J Clin Invest] 2020 May; Vol. 50 (5), pp. e13231. Date of Electronic Publication: 2020 May 05.
Typ publikacji:
Journal Article
MeSH Terms:
Antiviral Agents/*therapeutic use
Esophageal and Gastric Varices/*pathology
Hepatitis C, Chronic/*drug therapy
Hypertension, Portal/*physiopathology
Liver Cirrhosis/*physiopathology
Aged ; Disease Progression ; Elasticity Imaging Techniques ; Endoscopy, Digestive System ; Esophageal and Gastric Varices/blood ; Esophageal and Gastric Varices/etiology ; Esophageal and Gastric Varices/therapy ; Female ; Humans ; Hypertension, Portal/complications ; Liver Cirrhosis/blood ; Liver Cirrhosis/complications ; Male ; Middle Aged ; Organ Size ; Platelet Count ; Severity of Illness Index ; Spleen/pathology ; Sustained Virologic Response ; Treatment Outcome
Czasopismo naukowe
Tytuł:
Concerns related to COVID-19 pandemic among patients with inflammatory bowel disease and its influence on patient management.
Autorzy:
Bodini G; Gastroenterology Unit, Department of Internal Medicine, University of Genoa, IRCCS Ospedale Policlinico San Martino, Genoa, Italy.
Demarzo MG; Gastroenterology Unit, Department of Internal Medicine, University of Genoa, IRCCS Ospedale Policlinico San Martino, Genoa, Italy.
Casagrande E; Gastroenterology Unit, Department of Internal Medicine, University of Genoa, IRCCS Ospedale Policlinico San Martino, Genoa, Italy.
De Maria C; Gastroenterology Unit, Department of Internal Medicine, University of Genoa, IRCCS Ospedale Policlinico San Martino, Genoa, Italy.
Kayali S; Gastroenterology Unit, Department of Internal Medicine, University of Genoa, IRCCS Ospedale Policlinico San Martino, Genoa, Italy.
Ziola S; Gastroenterology Unit, Department of Internal Medicine, University of Genoa, IRCCS Ospedale Policlinico San Martino, Genoa, Italy.
Giannini EG; Gastroenterology Unit, Department of Internal Medicine, University of Genoa, IRCCS Ospedale Policlinico San Martino, Genoa, Italy.
Pokaż więcej
Źródło:
European journal of clinical investigation [Eur J Clin Invest] 2020 May; Vol. 50 (5), pp. e13233. Date of Electronic Publication: 2020 May 09.
Typ publikacji:
Letter; Comment
MeSH Terms:
Coronavirus*
Inflammatory Bowel Diseases*
Betacoronavirus ; COVID-19 ; Centers for Disease Control and Prevention, U.S. ; China ; Coronavirus Infections ; Humans ; Pandemics ; Pneumonia, Viral ; SARS-CoV-2 ; United States
Opinia redakcyjna
    Wyświetlanie 1-11 z 11

    Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies